Health Products

NOVASEN 325mg ENTERIC COATED TABLETS (DELAYED RELEASE) (2017-11-27)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Hospitals, Healthcare Professionals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
35341402BNOVASEN 325mg ENTERIC COATED TABLETS (DELAYED RELEASE)
Recalling Firm
Teva Canada Limited 30 Novopharm Court Toronto, ON M1B 2K9
Marketing Authorization Holder
Teva Canada Inc. 30 Novopharm Court Toronto, Ontario M1B 2K9
TabletDIN 00216666325 mg

Introduction

Affected products

NOVASEN 325mg ENTERIC COATED TABLETS (DELAYED RELEASE)

Reason

Out of specification for disintegration during stability testing.

Depth of distribution

Wholesalers and retailers: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Quebec and Saskatchewan
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime